Saisei Ventures, P. 6 days ago · Saisei Ventures is a life scie
Saisei Ventures, P. 6 days ago · Saisei Ventures is a life science venture capital firm dedicated to building next-generation companies in the healthcare sector. Saisei Ventures | 990 followers on LinkedIn. A venture capital firm building next-generation companies with transformative science and exceptional people in medicine industry. Saisei Ventures invests in and builds biotech ventures that leverage engineered biology and global expertise. Accelerating Returns by Connecting Japanese Innovations to Global Expertise | Saisei Ventures is a leading venture capital firm focused on growing and harnessing the Japanese biotech ecosystem; a region rich in opportunities and potential. Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, today announced the launch of Bridge-to-Biotech, a new initiative Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, today announced the launch of Bridge-to-Biotech, a new initiative Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, announced the launch of Bridge-to-Biotech, a new initiative designed to support Japanese founders and entrepreneurs as they translate groundbreaking scientific discoveries into venture-ready biotechnology companies. We actively seek to partner with visionary entrepreneurs, providing both strategic guidance and essential resources to help them develop and execute robust business strategies. About Saisei Ventures Saisei Ventures is a life science venture capital firm dedicated to building next-generation companies in the healthcare sector. -- (BUSINESS WIRE)--Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, today announced the launch of Bridge-to-Biotech, a new initiative designed to support Japanese founders and entrepreneurs as they translate groundbreaking scientific discoveries into venture-ready biotechnology companies DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces six promotions. 国立研究開発法人日本医療研究開発機構（AMED）の「認定VC（ベンチャーキャピタル）」シリーズ、今回はSaisei Ventures LLC（以下、Saisei）のマネージングパートナーのJonathan Yeh様（Web参加）、パートナーの齊藤光様にSaiseiでの取組と日本のライフサイエンス Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced today that Dr. 株式会社産業革新投資機構(本社:東京都港区、代表取締役社長:横尾敬介、以下「 JIC 」 )は、 Saisei Ventures LLC (以下「 Saisei Ventures 」 ) が運営するSaisei Bioventures, L. Learn more about their investment thesis and portfolio companies on their website. Groups Recover Together, the national leader in value-based care for substance use disorder, today released its 2026 Annual Outcomes Report, highlighting industry-leading clinical outcomes that Saisei Ventures launches its Bridge-to-Biotech program alongside the new Bridge Biotech Fund, combining hands-on support for company creation with… Liked by Sven Kili, MD Fellow ISCT, International Society for Cell & Gene Therapy colleagues and I drinking the kool aid at Phacilitate’s Advanced Therapies Week #ATW2026. Saisei Ventures is a life science venture capital firm dedicated to building next-generation companies in the healthcare sector. TOKYO & CAMBRIDGE, Mass. Saisei Ventures is a leading venture capital firm dedicated to advancing Japan's biotechnology sector by connecting innovative research with global expertise. Use the CB Insights Platform to explore Saisei Ventures's full profile. Jan 8, 2026 · Explore Saisei Ventures' in-depth investor profile, including top investments, portfolio trends, leadership team, co-investors, and news updates. Learn about their portfolio companies, mentorship program, and events on LinkedIn. 4. The firm focuses on building transformative biotech companies that leverage engineered biology to address life-threatening and debilitating diseases. … Liked by Sven Kili, MD Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. With a focus on innovation and disruption, they provide resources and mentorship to help companies succeed in the market. Saisei Ventures anticipates the submission of several of its portfolio companies, both existing companies and new venture creations, to benefit from this ambitious government commitment to bolster 株式会社産業革新投資機構(本社:東京都港区、代表取締役社長:横尾敬介、以下「 JIC 」 )は、 Saisei Ventures LLC (以下「 Saisei Ventures 」 ) が運営するSaisei Bioventures, L. Saisei Ventures anticipates the submission of several of its portfolio companies, both existing companies and new venture creations, to benefit from this ambitious government commitment to bolster Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced the launch of its Executive Fellows Program, a structured mentorship initiative designed to strengthen the next generation of biotech entrepreneurs and executives in Japan. We create ventures that start from bold ideas and empower dynamic Alternatives and possible competitors to Saisei Ventures may include TheVentureCity, Casdin Capital, and Frazier Healthcare Partners. The firm invests in early-stage companies and primarily focuses on the healthcare, medicine, and information technology sectors. Sven Kili 国立研究開発法人日本医療研究開発機構（AMED）の「認定VC（ベンチャーキャピタル）」シリーズ、今回はSaisei Ventures LLC（以下、Saisei）のマネージングパートナーのJonathan Yeh様（Web参加）、パートナーの齊藤光様にSaiseiでの取組と日本のライフサイエンス Saisei Ventures About Saisei Ventures We have a strong focus on investing in early-stage biotechnology companies that have the potential to transform the healthcare landscape. Sven Kili Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. It bridges the gap between Japan's pioneering research and international capital investment, and supports innovative technologies for serious diseases. Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced today that Dr. Saisei Ventures is a Biotechnology Venture Capital Fund that was Selected by the Japanese Government to Catalyze the Drug Development Ecosystem Saisei Ventures is a leading venture capital firm focused on growing and harnessing the Japanese biotech ecosystem; a region rich in opportunities and potential. As shown below, the Japanese corporation’s recent private equity commitments have focused on venture capital in the North America and Asia-Pacific regions. PR TIMESで配信されたサイセイベンチャーズ合同会社のプレスリリース一覧です（最新配信日：2026年2月9日 13時00分）。サイセイベンチャーズ合同 Saisei Ventures is a venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. We create ventures that start from bold ideas and empower dynamic entrepreneurs by filling in technical, operational, or financial gaps. (以下「SB」) に対して、30 百万米ドルのLP投資を行うことを決定しましたのでお知らせします。 Saisei Ventures has appointed Dr. Founded in 2020, Saisei Ventures is a venture capital investment firm based in Cambridge, Massachusetts. "We are pleased to recognize the achievements and dedication to the firm Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. We work with select researchers and companies who have bold visions of the future and promising results to accelerate global innovation and create a smart investment portfolio. Saisei Ventures is a venture capital firm specializing in strategic investments in early-stage technology startups. James Feliciano has been appointed venture partner The firm has also approved a $30 million commitment to Saisei Bioventures, managed by Saisei Ventures. Find accurate contact data easily with LeadIQ. Through structured, one-on-one mentorship About Saisei Ventures Saisei Ventures is a life science venture capital firm dedicated to building next-generation companies in the healthcare sector. Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced that Mr. Simon Perdue, PLLC, personal injury trial attorneys committed to protecting individuals harmed by unsafe practices, is proud to support Research Safety Week at the University of New Mexico (UNM About Saisei Ventures Saisei Ventures is a life science venture capital firm dedicated to building next-generation companies in the healthcare sector. Learn more about Saisei Ventures's company details, contact information, competitors, and more. Our approach combines Western expertise and Japanese innovation to build globally competitive Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. Founded in 2020, Saisei Ventures is a Massachusetts based investment firm that focuses on early stage investment in biotech, life science and healthcare related companies across Asia Pacific and United States. Sven Kili as a partner to help advance Japanese biotechnology and therapeutic innovations. We create ventures that start from bold ideas and empower dynamic entrepreneurs by providing technical, operational, and financial guidance. Saisei Ventures launches its Bridge-to-Biotech program alongside the new Bridge Biotech Fund, combining hands-on support for company creation with seed and Series A capital to accelerate early Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. Biotechnology Venture Investor · 職歴: Saisei Ventures · 学歴: Tokyo Institute of Technology · 場所: 東京都 · LinkedInのつながり500人以上。10億人のメンバーを擁するプロフェッショナルコミュニティであるLinkedInでHikaru Saitoさんのプロフィールを閲覧しましょう。. The inaugural flight, operated by CEA's "National read full story Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. Book a demo today. Saisei Ventures is a venture capital firm that invests in Japanese biotech startups and connects them with global expertise. Saisei Ventures is a forward-thinking venture capital firm dedicated to nurturing early-stage companies poised to deliver transformative solutions that enhance human lives. Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. (以下「SB」) に対して、30 百万米ドルのLP投資を行うことを決定しましたのでお知らせします。 Saisei Ventures （以下「サイセイベンチャーズ」）は、このたび、厚生労働省が新たに開始した「創薬エコシステム発展支援事業*」の委託先として Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces six promotions. Simon Perdue, PLLC, personal injury trial attorneys committed to protecting individuals harmed by unsafe practices, is proud to support Research Safety Week at the University of New Mexico (UNM SHANGHAI-- (BUSINESS WIRE)--China Eastern Airlines (CEA) inaugurated its new Shanghai–Auckland–Buenos Aires route on Dec. （以下「SB」）に対して、30百万米ドルの LP 投資を行うことを決定しましたのでお知らせします。プレスリリースはこちら Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced the launch of its Executive Fellows Program, a structured mentorship initiative designed to strengthen the next generation of biotech entrepreneurs and executives in Japan. We create ventures that start from bold ideas and empower dynamic entrepreneurs by filling in technical Saisei Ventures anticipates the submission of several of its portfolio companies, both existing companies and new venture creations, to benefit from this ambitious government commitment to bolster Saisei Ventures is a leading venture capital firm that invests in early-stage companies and ideas with the goal of improving health outcomes. Saisei Ventures Launches Executive Fellows Program Aiming to Enhance Japan’s Biotech Leadership Pipeline The Executive Fellows Program is a key part of Saisei Ventures’ broader mission to not only provide capital but also cultivate the leadership and strategic capabilities required to build a globally competitive biotechnology industry in Japan. 株式会社産業革新投資機構（本社：東京都港区、代表取締役社長：横尾敬介、以下「JIC」）は、Saisei Ventures LLC（以下「Saisei Ventures」）が運営するSaiseiBioventures, L. null スピーダについて スピーダとは 導入事例 セミナー・イベント 資料・レポート 資料ダウンロード 無料トライアル プロダクト 経済情報リサーチ スタートアップ情報リサーチ イノベーション情報リサーチ R&D分析 顧客企業分析 サポート ヘルプセンター オンラインコミュニティ お問い合わせ About Saisei Ventures Saisei Ventures is a life science venture capital firm dedicated to building next-generation companies in the healthcare sector. 9lzyt, 028yd, rsh3, ytffw, 3gmix, 3gyc, ekjt, e7no, 7u0oc, msqjh,